I'm honored to be joining the Governing Council of the National Academy of Medicine, along with four distinguished colleagues and the Academy's new Home Secretary, Dr. Robert L. Phillips. nam.edu/news-and-ins...

My essay in the Sunday Washington Post: “A viral infection can have devastating effects. I experienced this firsthand.” @washingtonpost.com wapo.st/3MhEY0U

My Op Ed in Today's Washington Post: "The long-lasting effects of viruses — and the anti-vaccine movement. For some people, a viral infection can have devastating long-term effects." wapo.st/4qjFtWk

It appears that the new dietary guidelines stopped short of strengthening the recommendation to reduce alcohol consumption and may have weakened it — a missed public health opportunity that should be revisited as these guidelines are refined and updated. www.nbcnews.com/news/amp/rcn...

To foster disruptive innovation with the potential to change medical paradigms, NIH policies should channel more funding to unconventional ideas and the early-career investigators who are pursuing them, a theme that I take up in my forthcoming book, Miracle Century www.statnews.com/2025/12/18/n...

12 former commissioners of the FDA came together to write a Perspectives piece for the New England Journal of Medicine; raising our concerns about recent changes to vaccine approval policy at the FDA and its implications for patients and public health.

My CNBC.com segment on implications for pediatric vaccine schedule from recent politics. 2003 saw ~5,000 cases of pertusis, in 2024 there were over 35,000, and for 2025, some models show 70,000+ We risk a return of communicable diseases in children. www.youtube.com/watch?v=00cI...

I’ll be coming up on @SquawkCNBC at 6:30 to discuss vaccine safety and public health.

FDA’s cancer review team overseeing breast and gynecological products has lost about 1/3 of its medical review staff and the malignant heme group will lose about 2/3 of its medical review staff—all to voluntary resignations clustered among seasoned reviewers insights.citeline.com/pink-sheet/a...

My Op Ed: President Trump often touted that his first administration approved more generic drugs than any in history. He had good reason to highlight the success. Recently, however, the FDA review team enabling these approvals was disbanded, and it may undo that historic progress. @statnews.com

Steve Usdin writing in BioCentury: “It’s official: FDA says its cuts are delaying drug regulation — Layoffs, lack of access to journals slow response FDA says”

I’ll be on Face the Nation tomorrow discussing the latest developments in healthcare policy

www.nbcnews.com/news/amp/rcn...

Measles outbreak in the U.S. continues to expand with 39 new cases in Texas (198 total) and 20 new cases in New Mexico (30 total) h/t BNO News

My segment on CNBC today on the expanding measles outbreak in Texas and the risk of further spread m.youtube.com/watch?v=Zl7w...

I’m on @facethenation.bsky.social this Sunday discussing latest developments related to avian flu and efforts to alleviate egg shortage, the ongoing Measles outbreak, and other health topics

Update on the Texas Measles outbreak: Cases doubled this week, with 48 known infections now, most in patients are under the age of 17. All of the cases are believed to have occurred in unvaccinated individuals, with 13 people hospitalized www.dshs.texas.gov/news-alerts/...

We’re experiencing perhaps the worst flu season in 25 years, with severe cases also rising, and young children and seniors faring the worst. One in six of all ER visits in the 0-17 age groups are now for influenza. www.cdc.gov/fluview/surv... h/t @cmyeaton.bsky.social

My essay in JAMA today on targeted reforms that FDA could make to help facilitate the adoption of AI to high value clinical applications inside electronic medical records — to improve physician precision and productivity, and patient outcomes jamanetwork.com/journals/jam...

I’m coming up on CNBC at 10:50 from the inauguration booth in Washington, with host Becky Quick, discussing the Trump Administration’s healthcare agenda and the outlook for innovation and continued advances in life sciences. @cnbc.com #TrumpInauguration

My segment on @cnbc.com today m.youtube.com/watch?v=oUJk...

I’m combing up on @cnbc.com at 7:30 AM where I’ll be discussing cough and cold season, along with emerging pathogens like H5N1 and steps to mitigate these potential risks.

FDA transfers regulatory oversight of medical maggots and leaches from its device center (the organisms previously regulated as medical devices) to biologics center public-inspection.federalregister.gov/2024-31266.p... More on their clinical applications here pmc.ncbi.nlm.nih.gov/articles/PMC...

Some of the most impactful research by NIH are inquiries into infectious diseases, including this from NIH’s 2024 highlights, a way to turn off prion-producing genes that reduced prion protein levels by 80%, suggesting a new approach for treating prion diseases in people. www.nih.gov/news-events/...